Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $385.96 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $114.57 | 2 | $0 (2017) |
| Genentech USA, Inc. | $74.27 | 1 | $0 (2018) |
| ABBVIE INC. | $65.51 | 4 | $0 (2024) |
| CSL Behring | $57.32 | 3 | $0 (2022) |
| PFIZER INC. | $35.39 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $28.29 | 2 | $0 (2024) |
| ZS Pharma. Inc. | $10.61 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $116.88 | 7 | ABBVIE INC. ($65.51) |
| 2022 | $24.65 | 1 | CSL Behring ($24.65) |
| 2021 | $20.81 | 1 | CSL Behring ($20.81) |
| 2018 | $86.13 | 2 | Genentech USA, Inc. ($74.27) |
| 2017 | $137.49 | 4 | E.R. Squibb & Sons, L.L.C. ($114.57) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/17/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/05/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/09/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/03/2022 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 05/19/2021 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 12/13/2018 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 09/11/2018 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $74.27 | General |
| 11/30/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/02/2017 | ZS Pharma. Inc. | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $7.82 | General |
| Category: Cardiovascular | ||||||
| 10/17/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $106.75 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 189 | 193 | $65,370 | $25,113 |
| 2022 | 3 | 166 | 169 | $58,574 | $23,510 |
| 2021 | 5 | 334 | 337 | $104,864 | $41,488 |
| 2020 | 5 | 324 | 326 | $99,130 | $38,233 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 98 | 101 | $35,249 | $13,560 | 38.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 43 | 43 | $18,361 | $6,960 | 37.9% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 48 | 49 | $11,760 | $4,593 | 39.1% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 107 | 110 | $37,865 | $15,668 | 41.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 32 | 32 | $14,429 | $5,498 | 38.1% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 27 | 27 | $6,280 | $2,344 | 37.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 127 | 127 | $41,148 | $17,694 | 43.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 81 | 81 | $41,472 | $13,980 | 33.7% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 76 | 76 | $16,720 | $7,184 | 43.0% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 35 | 37 | $4,292 | $2,136 | 49.8% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2021 | 15 | 16 | $1,232 | $493.78 | 40.1% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 107 | 108 | $34,992 | $14,343 | 41.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 79 | 79 | $40,448 | $13,925 | 34.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 77 | 78 | $17,160 | $7,161 | 41.7% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 47 | 47 | $5,452 | $2,325 | 42.6% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2020 | 14 | 14 | $1,078 | $479.11 | 44.4% |
About Dr. Krista Kandel, M.D
Dr. Krista Kandel, M.D is a Emergency Medicine healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1407032477.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Krista Kandel, M.D has received a total of $385.96 in payments from pharmaceutical and medical device companies, with $116.88 received in 2024. These payments were reported across 15 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($385.96).
As a Medicare-enrolled provider, Kandel has provided services to 1,013 Medicare beneficiaries, totaling 1,025 services with total Medicare billing of $128,343. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Emergency Medicine
- Location Syracuse, NY
- Active Since 01/21/2008
- Last Updated 12/07/2021
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1407032477
Products in Payments
- ELIQUIS (Drug) $149.96
- Kcentra (Biological) $57.32
- DALVANCE (Drug) $34.95
- XARELTO (Drug) $28.29
- UBRELVY (Drug) $16.13
- TEFLARO (Drug) $14.43
- BRILINTA (Drug) $10.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Syracuse
David Mason, Md, MD
Emergency Medicine — Payments: $1,580
Ross Sullivan, Md, MD
Emergency Medicine — Payments: $1,510
Fouad Boulos, Md, MD
Emergency Medicine — Payments: $878.53
Mark Stever, Rpa, RPA
Emergency Medicine — Payments: $860.86
Kevin Stimson, M.d, M.D
Emergency Medicine — Payments: $546.44
Richard Steinmann, Md, MD
Emergency Medicine — Payments: $544.35